Session Details

Improving compliance with low-dose acetylsalicylic acid (ASA) – New insights
28 Aug 12:45 - 13:30 Antithrombotic agents EBAC Accredited Educational Programme Ankara - Zone F
Chairpersons: Gilles MONTALESCOT (Paris, FR), Freek VERHEUGT (Amsterdam, NL)
Subtitle: EBAC Accredited Educational Programme organised by the Sahlgrenska Academy - Goteborg University / Course Director: Prof. K. Swedberg / Programme supported by an unrestricted educational grant from AstraZeneca

Presentations list

Related documents
12:45990Welcome and introduction.Freek VERHEUGT (Amsterdam, NL), Gilles MONTALESCOT (Paris, FR)
12:55991Clinical importance of low-dose acetylsalicylic acid and the consequences of non-compliance.Harald DARIUS (Berlin, DE)
13:05992High-risk cardiovascular patients - Clinical implications of gastrointestinal risk.Freek VERHEUGT (Amsterdam, NL)
13:15993Reducing the gastrointestinal risks of antiplatelet therapy.James SCHEIMAN (Ann Arbor, US)
13:25994Discussion and concluding remarks.Freek VERHEUGT (Amsterdam, NL)

Who we are

What we do

How we work

More ESC